top of page
blob-0001 (1).png

Consulting Services Provided Since 2020
ranging from short duration program strategy planning and execution to longer term team integration and cross-functional collaborations

 

blob-0001 (1)_edited.png
blob-0001 (1)_edited.png

Ophthalmology

Neurological

Muscular

CNS

Autoimmune 

Multi-Organ

Metabolic

​​​​​​INDICATIONS

Alzheimer Disease

Rett Syndrome

Glaucoma

RGC Preservation

Rod/Cone Dystrophy

MASH

Neuro-Muscular Junction

Prion Disease

Wound Healing

Duchenne Muscular Disease

Additional undisclosed diseases 

​

Adults and Pediatrics

​REGULATORY SUBMISSIONS ​

FDA

5 pre-INDs, IDE, INTERACT, Orphan Drug Designations​

​

MHRA : pre-CTA​, CTA

​

MODALITIES ​

Gene Therapy: AAV, HSV

cDNA, Zinc-Fingers 

Small Molecule

Device

 

Intrathecal, ICM

IV-Oral cross-over

Intravitreal, Subretinal

Screenshot 2026-06-09 091751.png
Screenshot 2026-06-09 094718.png
Screenshot 2026-06-09 094243.png
Screenshot 2026-06-09 094530.png
Screenshot 2026-06-09 095412.png

Vedere Bio

Screenshot 2026-06-09 095716.png
Screenshot 2026-06-09 102753.png
Screenshot 2026-06-09 103314.png
Screenshot 2026-06-09 103659.png
Screenshot 2026-06-09 103525.png

How may we support your team?

All prospective partnerships start with a complimentary one‑hour consultation, provided entirely obligation‑free

Resource Links
 

©2026 Bellemina Therapeutics LLC

bottom of page